Literature DB >> 21874402

C-reactive protein is associated with the progression of acute embolic stroke in rabbit model.

Qi Yu1, Yan Lin, Peigang Yang, Yanli Wang, Sihai Zhao, Penghui Yang, Jianglin Fan, Enqi Liu.   

Abstract

Several lines of evidence have shown that plasma C-reactive protein (CRP) is associated with increased risk of stroke; however, previous studies were not adequately powered to assess whether plasma CRP levels are associated with stroke progression. In the current study, we designed a rabbit stroke model and investigated the relationship between plasma CRP and infarcted brain tissue. To produce a rabbit stroke model, we injected autologous thrombi into the left internal carotid artery. The plasma CRP levels were measured by ELISA at 0.5, 3, 6, 9, and 12 h poststroke. At 12 h, the rabbits were sacrificed, and the whole brains were examined by H &amp; E and immunohistochemical staining with a monoclonal antibody against rabbit CRP. CRP mRNA expression in the infarcted tissue was evaluated by RT-PCR. Plasma CRP was markedly increased after embolic stroke. Plasma CRP positively correlated with the cerebral infarct area (r = 0.98, P < 0.01). Immunohistochemical staining revealed that CRP was frequently present in the infarcted area but not in normal cerebral tissue. RT-PCR showed that CRP was expressed in infarcted brain tissue. The plasma CRP level was significantly elevated after stroke and was closely correlated with the size of infarction, suggesting that CRP is an ideal marker to assess the acute embolic stroke.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21874402     DOI: 10.1007/s11239-011-0627-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  25 in total

1.  C-reactive protein and outcome after ischemic stroke.

Authors:  K W Muir; C J Weir; W Alwan; I B Squire; K R Lees
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

Review 2.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

3.  The relationship between inflammatory markers and post stroke cognitive impairment.

Authors:  Lana S Rothenburg; Nathan Herrmann; Walter Swardfager; Sandra E Black; Gayla Tennen; Alexander Kiss; David J Gladstone; Jon Ween; Abraham Snaiderman; Krista L Lanctôt
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-07-02       Impact factor: 2.680

Review 4.  Linking infection and inflammation in acute ischemic stroke.

Authors:  H Worthmann; A B Tryc; M Deb; A Goldbecker; Y T Ma; A Tountopoulou; R Lichtinghagen; K Weissenborn
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

5.  Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey.

Authors:  E S Ford; W H Giles
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

6.  Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro.

Authors:  Mark Slevin; Sabine Matou-Nasri; Marta Turu; Ana Luque; Norma Rovira; Lina Badimon; Susana Boluda; Lawrence Potempa; Coral Sanfeliu; Nuria de Vera; Jerzy Krupinski
Journal:  Brain Pathol       Date:  2009-01-19       Impact factor: 6.508

7.  Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

Authors:  Paul M Ridker; Eleanor Danielson; Francisco Ah Fonseca; Jacques Genest; Antonio M Gotto; John Jp Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G Macfadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

8.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  S G Thompson; J Kienast; S D Pyke; F Haverkate; J C van de Loo
Journal:  N Engl J Med       Date:  1995-03-09       Impact factor: 91.245

9.  C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.

Authors:  Wolfgang Koenig; Hannelore Löwel; Jens Baumert; Christa Meisinger
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

10.  Microfibrillar collagen model of canine cerebral infarction.

Authors:  P D Purdy; M D Devous; H H Batjer; C L White; Y Meyer; D S Samson
Journal:  Stroke       Date:  1989-10       Impact factor: 7.914

View more
  4 in total

1.  Systemic and flap inflammatory response associates with thrombosis in flap venous crisis.

Authors:  Wei Du; Pan-Feng Wu; Li-Ming Qing; Cong-Yang Wang; Jie-Yu Liang; Fang Yu; Ju-Yu Tang
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

2.  Expression of TRPV1 in rabbits and consuming hot pepper affects its body weight.

Authors:  Qi Yu; Yanli Wang; Ying Yu; Yafeng Li; Sihai Zhao; Yulong Chen; Ahmed Bilal Waqar; Jianglin Fan; Enqi Liu
Journal:  Mol Biol Rep       Date:  2012-02-11       Impact factor: 2.316

Review 3.  Monomeric C-Reactive Protein: Current Perspectives for Utilization and Inclusion as a Prognostic Indicator and Therapeutic Target.

Authors:  Mark Slevin; Nima Heidari; Leonard Azamfirei
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

4.  Differences of circulating inflammatory markers between large- and small vessel disease in patients with acute ischemic stroke.

Authors:  Lili Zeng; Xiaosong He; Jianrong Liu; Ling Wang; Suiqing Weng; Yongting Wang; Shengdi Chen; Guo-Yuan Yang
Journal:  Int J Med Sci       Date:  2013-08-22       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.